Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts

A. Guerrasio, C. Pilatrino, D. De Micheli, D. Cilloni, A. Serra, E. Gottardi, A. Parziale, F. Marmont, D. Diverio, M. Divona, F. Lo Coco, G. Saglio

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts'. Together they form a unique fingerprint.

Medicine & Life Sciences